Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial

James R. Seibold, Joseph H. Korn, Robert Simms, Phillip J. Clements, Larry W. Moreland, Maureen D. Mayes, Daniel E. Furst, Naomi Rothfield, Virginia Steen, Michael Weisman, David Collier, Fredrick M. Wigley, Peter A. Merkel, Mary Ellen Csuka, Vivien Hsu, Susan Rocco, Mark Erikson, John Hannigan, W. Scott Harkonen, Martin E. Sanders